Male breast cancer

Edward M. DeSimone, Michael H. Davidian, Amy Pick, Gamini Soori

Research output: Contribution to specialist publicationArticle

Abstract

Male breast cancer is an uncommon but potentially deadly disorder. One man for every 100 women is affected. There were approximately 2,000 cases in 2007, with 450 deaths. Male breast cancer is diagnosed and treated much like female breast cancer, with surgery the primary treatment. Other treatment modalities include radiation, hormone therapy with tamoxifen or aromatase inhibitors, biological agents such as trastuzumab, and chemotherapy with agents such as doxorubicin and paclitaxel. Because male breast cancer often metastasizes to the bone, bisphosphonates are used to prevent skeletal problems and alleviate pain. Survival is based on the extent of the cancer's invasiveness (staging).

Original languageEnglish
Volume33
No10
Specialist publicationU.S. Pharmacist
StatePublished - 2008

Fingerprint

Male Breast Neoplasms
Aromatase Inhibitors
Chemotherapy
Diphosphonates
Biological Factors
Tamoxifen
Paclitaxel
Doxorubicin
Surgery
Bone
Hormones
Radiation
Neoplasm Staging
Radiotherapy
Breast Neoplasms
Bone and Bones
Drug Therapy
Pain
Survival
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Pharmacology
  • Pharmacy

Cite this

DeSimone, E. M., Davidian, M. H., Pick, A., & Soori, G. (2008). Male breast cancer. U.S. Pharmacist, 33(10).

Male breast cancer. / DeSimone, Edward M.; Davidian, Michael H.; Pick, Amy; Soori, Gamini.

In: U.S. Pharmacist, Vol. 33, No. 10, 2008.

Research output: Contribution to specialist publicationArticle

DeSimone, EM, Davidian, MH, Pick, A & Soori, G 2008, 'Male breast cancer' U.S. Pharmacist, vol. 33, no. 10.
DeSimone EM, Davidian MH, Pick A, Soori G. Male breast cancer. U.S. Pharmacist. 2008;33(10).
DeSimone, Edward M. ; Davidian, Michael H. ; Pick, Amy ; Soori, Gamini. / Male breast cancer. In: U.S. Pharmacist. 2008 ; Vol. 33, No. 10.
@misc{03a6cc2f50444edeadc3e8b7a6838f3e,
title = "Male breast cancer",
abstract = "Male breast cancer is an uncommon but potentially deadly disorder. One man for every 100 women is affected. There were approximately 2,000 cases in 2007, with 450 deaths. Male breast cancer is diagnosed and treated much like female breast cancer, with surgery the primary treatment. Other treatment modalities include radiation, hormone therapy with tamoxifen or aromatase inhibitors, biological agents such as trastuzumab, and chemotherapy with agents such as doxorubicin and paclitaxel. Because male breast cancer often metastasizes to the bone, bisphosphonates are used to prevent skeletal problems and alleviate pain. Survival is based on the extent of the cancer's invasiveness (staging).",
author = "DeSimone, {Edward M.} and Davidian, {Michael H.} and Amy Pick and Gamini Soori",
year = "2008",
language = "English",
volume = "33",
journal = "U.S. Pharmacist",
issn = "0148-4818",
publisher = "Jobson Publishing Corporation",

}

TY - GEN

T1 - Male breast cancer

AU - DeSimone, Edward M.

AU - Davidian, Michael H.

AU - Pick, Amy

AU - Soori, Gamini

PY - 2008

Y1 - 2008

N2 - Male breast cancer is an uncommon but potentially deadly disorder. One man for every 100 women is affected. There were approximately 2,000 cases in 2007, with 450 deaths. Male breast cancer is diagnosed and treated much like female breast cancer, with surgery the primary treatment. Other treatment modalities include radiation, hormone therapy with tamoxifen or aromatase inhibitors, biological agents such as trastuzumab, and chemotherapy with agents such as doxorubicin and paclitaxel. Because male breast cancer often metastasizes to the bone, bisphosphonates are used to prevent skeletal problems and alleviate pain. Survival is based on the extent of the cancer's invasiveness (staging).

AB - Male breast cancer is an uncommon but potentially deadly disorder. One man for every 100 women is affected. There were approximately 2,000 cases in 2007, with 450 deaths. Male breast cancer is diagnosed and treated much like female breast cancer, with surgery the primary treatment. Other treatment modalities include radiation, hormone therapy with tamoxifen or aromatase inhibitors, biological agents such as trastuzumab, and chemotherapy with agents such as doxorubicin and paclitaxel. Because male breast cancer often metastasizes to the bone, bisphosphonates are used to prevent skeletal problems and alleviate pain. Survival is based on the extent of the cancer's invasiveness (staging).

UR - http://www.scopus.com/inward/record.url?scp=59849086362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59849086362&partnerID=8YFLogxK

M3 - Article

VL - 33

JO - U.S. Pharmacist

JF - U.S. Pharmacist

SN - 0148-4818

ER -